Selected
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2623 results found
2025 ∙ Blukacz, A. Obach, A. Vasquez, P. Campana, C. Huerta, C. Bernal, Y. Cabieses, B.
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis
Low and Middle Income Countries All age groups COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
Adolescents Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Azam, B. Marti, M. Goel, A. Aggarwal, R.
Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review
All age groups Hepatitis E Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Yeshiwas, A. G. Tsega, T. D. Denku, C. Y. Jember, M. N. Aynalem, Z. B. Ayalew, M. D. Wondimu, A. T. Alemu, A. S. Tessema, M. T. Mehari, M. G. Berihun, S. Bayeh, G. M.
Mpox vaccine acceptance and its predictors among people who have risky sexual practices: A systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Hegazi, M. A. Sayed, M. H. Butt, N. S. Alahmadi, T. S. Zubairi, N. A. Elson, W. A.
Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis
Parents/caregivers Saudi Arabia COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Gaidhane, S. Padmapriya, G. Kaur, I. Lal, M. Iqbal, S. Prasad, G. V. S. Pramanik, A. Sharma, P. Malik, P. Vishwakarma, T. Punia, A. Jagga, M. Mehta, R. Sah, S. Shabil, M. Satapathy, P. Bushi, G. Parsa, A. D. Kabir, R.
Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis
Adolescents Adults Mpox Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.
Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Askar, M. Ali, K. A. Batke, M. Brugger, T. Falman, A. Robertson, A. H. Perez, J. J. Johansen, K. de Jonge, J. Krause, T. G. Kulper-Schiek, W. Meerpohl, J. J. Melidou, A. Nohynek, H. Olmedo, C. Olsson, K. Pavlopoulou, I. Piechotta, V. Rubin, J. Schlaberg, J. Schmucker, C. Siemens, W. Stratil, J. Ucakar, V. Wichmann, O. Harder, T.
Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review
Adults Older adults Influenza Efficacy/effectiveness Safety
Rating:
High
2025 ∙ Li, Y. Liu, Z. Zhou, L. Li, R.
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis
All age groups China Economic aspects Acceptance
Rating:
Not applicable
2024 ∙ Nangsue, C. Srisurapanont, K. Sudjaritruk, T.
A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low